KBIO

KaloBios Pharmaceuticals, Inc. News Headlines

$2.4
*  
0.22
 negative 
8.4%
Get KBIO Alerts
*Delayed - data as of Apr. 23, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

KaloBios Pharma To Present At Needham Conference; Webcast At 11:20 AM ET
4/8/2014 10:20:00 AM - RTT News

KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape
4/3/2014 9:28:01 AM - Zacks.com

CADX Snapped Up, HNSN Gets FDA Nod, NNVC Rejects Report's Claims, NVLT Renamed
2/12/2014 1:21:00 AM - RTT News

KaloBios (KBIO) Crumbles: Stock Falls by 6.3% - Tale of the Tape
2/3/2014 9:46:01 AM - Zacks.com

KaloBios to Stop KB003 Development for Asthma - Analyst Blog
1/30/2014 7:50:01 PM - Zacks.com

U.S. Hot Stock Futures: Hot Stocks to Watch
1/30/2014 9:26:00 AM - Dow Jones Business News

KaloBios: KB003 Fails To Meet Primary Goal In Phase 2 Asthma Study
1/29/2014 11:57:00 PM - RTT News

DEPO Prevails In Markman Hearing, IDIX, KBIO Get Smacked, ONVO Ahead Of Target
1/29/2014 11:32:00 PM - RTT News

KaloBios Pharma's Phase 2 Study Of KB003 Fails To Meet Primary Endpoint
1/29/2014 7:00:00 PM - RTT News

KaloBios Pharmaceuticals: Undervalued Company With Huge Potential Catalyst
12/27/2013 11:11:00 AM - Seeking Alpha

Actavis Cuts 350 Sales Positions in the U.S. - Analyst Blog
11/22/2013 12:50:01 PM - Zacks.com

KaloBios Prices Stock Offering - Analyst Blog
9/27/2013 4:33:39 PM - Zacks.com

KaloBios to Raise Funds - Analyst Blog
9/24/2013 4:17:43 PM - Zacks.com

Data on KaloBios' KB001 Published - Analyst Blog
9/20/2013 6:25:01 PM - Zacks.com

KaloBios Loss Wider-than-Expected - Analyst Blog
8/22/2013 2:35:01 PM - Zacks.com

KaloBios: An Undervalued Pharmaceutical Company With Remarkable Pipeline
6/13/2013 2:51:00 PM - Seeking Alpha

KaloBios Pharma Incurs Wider Loss - Analyst Blog
4/3/2013 1:22:08 PM - Zacks.com

KaloBios Pharmaceuticals - A Failed Public Offering Waiting For Good News
2/19/2013 4:33:00 PM - Seeking Alpha

5 Stocks With Recent Intensive Insider Buying
2/6/2013 10:28:00 AM - Seeking Alpha

Most January Pricings Since 2006, Zoetis Surges In Debut
2/5/2013 5:55:00 AM - Seeking Alpha

Weekly recap: Most January pricings since 2006, Zoetis surges in debut
2/1/2013 6:13:06 PM - Renaissance Capital

KaloBios prices upsized deal at $8, at low end of the range
1/31/2013 9:09:04 AM - Renaissance Capital

IPO Preview: KaloBios Pharmaceuticals
1/30/2013 5:28:00 PM - Seeking Alpha

KaloBios revises IPO terms; lowers range, increases shares offered
1/30/2013 1:53:21 PM - Renaissance Capital

5 IPOs Planned For This Week
1/28/2013 4:07:00 PM - Seeking Alpha